Proposition - PharmXpert Academy
Proposition - PharmXpert Academy
Proposition - PharmXpert Academy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
324 2007 Korea Pharmaceutical Industry Directory<br />
4. Patent Information<br />
No<br />
The Name of Technology<br />
Application<br />
No.<br />
(Application<br />
date)<br />
Publication No.<br />
(Publication<br />
date)<br />
Priority No.<br />
Applied<br />
Country For<br />
Global<br />
Development<br />
Stage<br />
Future<br />
Plan<br />
Expected<br />
Licencing<br />
(Domestic,<br />
Oversea)<br />
1<br />
ANTIOBESITY<br />
COMPOSITION<br />
PCT/KR200<br />
6/004049<br />
(9 Oct 2006)<br />
WO 2007/040377<br />
(12 April 2007)<br />
KR<br />
10-2005-009<br />
3577<br />
Korea<br />
(USA EU<br />
AU BZ CA<br />
CN JP)<br />
clinical ph Ⅱ<br />
prep<br />
product<br />
launch<br />
Domestic.<br />
Oversea<br />
2<br />
COMPOSITION<br />
COMPRISING MELISSA<br />
LEAF EXTRACT FOR<br />
ANTI-ANGIOGENIC<br />
AND MATRIX<br />
METALLOPROTEINASE<br />
INHIBITORY ACTIVITY<br />
PCT/KR01/<br />
02148 (12<br />
Dec 2001)<br />
WO 02/47701<br />
(20 June 2002)<br />
KR<br />
2000/75488<br />
KR<br />
2001/8470<br />
KR<br />
2001/77392<br />
Korea USA<br />
EU China<br />
Japan<br />
pre-clinical<br />
Domestic.<br />
Oversea<br />
COMPOSITION FOR<br />
3<br />
THE PREVENTION OR<br />
TREATMENT OF<br />
DISEASES ASSOCIATED<br />
WITH ANGIOGENESIS<br />
11/118,714<br />
(30 April<br />
2005)<br />
US-2006-0246157<br />
(2 Nov 2006)<br />
KR<br />
2003/77120<br />
Korea<br />
USA<br />
pre-clinical<br />
Domestic.<br />
Oversea<br />
COMPOSITION<br />
4<br />
CONTAINING GINKGO<br />
BILOBA THAT INHIBIT<br />
ANGIOGENESIS AND<br />
MATRIX<br />
METALLOPROTEINASE<br />
PCT/KR01/<br />
01325<br />
(3 Aug 2001)<br />
WO 02/11745<br />
(14 Feb 2002)<br />
KR<br />
2000/45265<br />
KR<br />
2001/11850<br />
Korea<br />
USA<br />
pre-clinical<br />
Domestic.<br />
Oversea<br />
COMPOSITION<br />
CONTAINING HORSE<br />
5<br />
CHESTNUT EXTRACT<br />
FOR<br />
ANTI-ANGIOGENIC<br />
AND MATRIX<br />
METALLOPROTEINASE<br />
INHIBITORY ACTIVITY<br />
PCT/KR02/<br />
02000<br />
(25 Oct 2002)<br />
WO 03/035092<br />
( 1 May 2003)<br />
KR<br />
2001/66246<br />
KR<br />
2002/63407<br />
Korea<br />
USA<br />
EU<br />
pre-clinical<br />
Domestic.<br />
Oversea<br />
6<br />
USE OF PAEONOL FOR<br />
INHIBITING<br />
ANGIOGENESIS OR<br />
FOR ENHANCING<br />
RADIOSENSITIZATION<br />
PCT/KR200<br />
6/001702<br />
(4 May 2006)<br />
WO 2006/121263<br />
(16 Nov 2006)<br />
KR<br />
2001/66246<br />
KR<br />
2002/63407<br />
Korea<br />
USA<br />
EU<br />
pre-clinical<br />
Domestic.<br />
Oversea
Change language